Thermovision-controlled lumbar sympathetic blockade in chronic limb-threatening ischemia treatment
Chronic limb-threatening ischemia (CLTI), the end-stage of lower extremity artery disease (LEAD), occurs with growing prevalence around the globe and is associated with increased healthcare costs. CLTI is defined by the presence of LEAD in combination with rest pain, gangrene, or lower limb ulceration lasting more than two weeks. Despite unclear results of abdominal surgical lumbar sympathectomy, novel interventional minimally invasive fluoroscopy-guided procedures seem to be promising. A prospective interventional study will be conducted, primarily targeting patients afflicted by critical limb ischemia, with the incorporation of thermal vision control and tissue oxygen monitoring.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
60
Skiascopic-guided lumbar sympathetic blockade with the administration of local anesthetic
Europainclinics
Košice, Slovakia
RECRUITINGChange From Baseline EuroQoL-5 Dimension (EQ-5D) Value 3m
EQ-5D-5L self-care, usual activities, pain/discomfort and anxiety/depression
Time frame: 3 months follow-up
Change From Baseline EuroQoL-5 Dimension (EQ-5D) Value 6m
EQ-5D-5L self-care, usual activities, pain/discomfort and anxiety/depression
Time frame: 6 months follow-up
Change From Baseline Visual Analog Pain Scale (VAS) of Back Pain 3m
Change From Baseline Visual Analog Pain Scale (VAS) of Back Pain 3m measured by VAS 10 point measurement
Time frame: 3 months follow-up
Change From Baseline Visual Analog Pain Scale (VAS) of Back Pain 6m
Change From Baseline Visual Analog Pain Scale (VAS) of Back Pain 6m measured by VAS 10 point measurement
Time frame: 6 months follow-up
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.